Related Experiment Video
Updated: Jan 5, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary Hypertension in General Cardiology Practice
Daniela Calderaro1, José Leonidas Alves Junior1, Caio Júlio César Dos Santos Fernandes1
1Instituto do Coração - Hospital das Clínicas HCFMUSP - Faculdade de Medicina - Universidade de São Paulo, São Paulo, SP - Brazil.
Echocardiography suggests pulmonary hypertension (PH), but invasive monitoring confirms diagnosis and identifies the cause. Specific PH medications benefit pulmonary arterial hypertension but can harm PH from left heart disease.
Area of Science:
- Cardiology
- Pulmonology
- Medical Diagnostics
Background:
- Echocardiography commonly suggests pulmonary hypertension (PH), raising clinical concern.
- Echocardiography provides a suggestive, non-diagnostic assessment for PH.
- Invasive hemodynamic monitoring is the gold standard for PH diagnosis.
Purpose of the Study:
- To review diagnostic criteria for pulmonary hypertension.
- To outline etiological investigation and clinical classification of PH.
- To discuss therapeutic recommendations for different types of PH.
Main Methods:
- Review of current literature on pulmonary hypertension diagnosis and treatment.
- Discussion of echocardiography findings and invasive hemodynamic monitoring.
- Analysis of treatment efficacy and risks based on PH etiology.
Main Results:
- Invasive monitoring confirms PH diagnosis and differentiates arterial pulmonary from postcapillary PH.
- Specific PH medications are effective for pulmonary arterial hypertension.
- Certain PH medications can be detrimental in PH due to left heart disease.
Conclusions:
- Accurate PH diagnosis requires invasive hemodynamic assessment.
- Treatment strategies for PH must be tailored to the underlying cause.
- Distinguishing PH subtypes is critical for effective and safe therapeutic interventions.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Embolism I: Introduction
Cardiomyopathy V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

